ATOSSA THERAPEUTICS, INC. Cash and Cash Equivalents
ATOSSA THERAPEUTICS, INC. (ATOS) had Cash and Cash Equivalents of $26.09 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-07
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $26.09M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $31.72M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $41.30M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $51.84M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $26.09M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $31.72M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $41.30M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $51.84M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $57.86M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $65.12M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $71.08M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $74.77M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $79.53M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $83.96M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $88.46M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $94.03M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $99.39M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $103.87M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $110.89M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $117.37M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $125.54M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $131.49M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $136.38M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $140.04M 10-Q · filed 2022-11-07 | $140.04M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $142.43M 10-Q · filed 2022-08-08 | $142.43M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $137.57M 10-Q · filed 2022-05-09 | $137.57M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $39.55M 10-K · filed 2022-02-28 | $39.55M 10-K · filed 2021-03-31 |
| 2020-09-30 | $9.11M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $7.46M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $9.35M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $12.58M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $15.29M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $17.06M 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $19.57M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $10.38M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $12.94M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $15.24M 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $4.78M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $7.22M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $2.73M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $3.69M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.17M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $3.03M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $4.39M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $1.19M 10-Q · filed 2017-08-14 | |
| 2016-03-31 | $2.88M 10-Q · filed 2017-05-11 | |
| 2015-12-31 | $3.72M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $7.84M 10-Q/A · filed 2017-03-21 | |
| 2015-06-30 | $11.40M 10-Q/A · filed 2017-03-21 | |
| 2015-03-31 | $9.73M 10-Q/A · filed 2017-03-21 | |
| 2014-12-31 | $8.50M 10-K/A · filed 2017-03-21 | |
| 2014-09-30 | $11.37M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $14.30M 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $16.59M 10-Q · filed 2015-05-13 | |
| 2013-12-31 | $6.34M 10-K · filed 2016-03-30 | |
| 2013-09-30 | $7.69M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $2.44M 10-Q · filed 2014-08-12 | |
| 2013-03-31 | $1.39M 10-Q · filed 2014-05-14 | |
| 2012-12-31 | $1.73M 10-K · filed 2015-03-30 | |
| 2012-09-30 | $418.57K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $88.00K 10-Q · filed 2013-08-14 | |
| 2012-03-31 | $899.49K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $1.91M 10-K · filed 2014-03-27 | |
| 2011-09-30 | $3.01M 10-Q/A · filed 2013-01-22 | |
| 2010-12-31 | $10.25K 10-K · filed 2013-03-28 | |
| 2009-04-30 | $0.00 10-K · filed 2014-03-27 | |
| 2009-04-29 | $0.00 10-Q · filed 2014-05-14 | |
| 2009-04-27 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |